$2.93
PDS Biotechnology is a biotechnology business based in the US. PDS Biotechnology shares (PDSB) are listed on the NASDAQ and all prices are listed in US Dollars. PDS Biotechnology employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy PDS Biotechnology stock
How to buy PDS Biotechnology stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PDSB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy PDS Biotechnology stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
PDS Biotechnology stock price (NASDAQ: PDSB)
Use our graph to track the performance of PDSB stocks over time.PDS Biotechnology shares at a glance
Latest market close | $3.00 |
---|---|
52-week range | $2.53 - $6.85 |
50-day moving average | $3.37 |
200-day moving average | $4.21 |
Wall St. target price | $12.40 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.23 |
Is it a good time to buy PDS Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PDS Biotechnology price performance over time
Historical closes compared with the close of $3 from 2024-09-05
1 week (2024-08-30) | -6.25% |
---|---|
1 month (2024-08-07) | 3 |
3 months (2024-06-07) | 2.92% |
6 months (2024-03-07) | -48.45% |
1 year (2023-09-07) | -49.32% |
---|---|
2 years (2022-09-07) | -27.88% |
3 years (2021-09-07) | 15.67 |
5 years (2019-09-06) | 5.5 |
PDS Biotechnology financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -39.95% |
Return on equity TTM | -128.4% |
Profit margin | 0% |
Book value | $0.84 |
Market Capitalization | $117.8 million |
TTM: trailing 12 months
PDS Biotechnology share dividends
We're not expecting PDS Biotechnology to pay a dividend over the next 12 months.
Have PDS Biotechnology's shares ever split?
PDS Biotechnology's shares were split on a 1:20 basis on 17 March 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PDS Biotechnology shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for PDS Biotechnology shares which in turn could have impacted PDS Biotechnology's share price.
PDS Biotechnology share price volatility
Over the last 12 months, PDS Biotechnology's shares have ranged in value from as little as $2.53 up to $6.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PDS Biotechnology's is 1.89. This would suggest that PDS Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PDS Biotechnology overview
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein (TARP) for treating prostate and breast cancers; and PDS0103 for ovarian, colorectal, lung, and breast cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment; and PDS0104, a novel investigational Tyrosinase-related Protein 2 targeted immunotherapy that stimulates a potent targeted T cell attack against melanoma. Further, the company provides PDS0202, a novel investigational influenza vaccine that generates broad and robust antibody and T cell responses that provide protection against continually evolving strains of seasonal flu and potentially emerging pandemic flu. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U. S.
Frequently asked questions
What percentage of PDS Biotechnology is owned by insiders or institutions?Currently 3.992% of PDS Biotechnology shares are held by insiders and 15.065% by institutions. How many people work for PDS Biotechnology?
Latest data suggests 25 work at PDS Biotechnology. When does the fiscal year end for PDS Biotechnology?
PDS Biotechnology's fiscal year ends in December. Where is PDS Biotechnology based?
PDS Biotechnology's address is: 303A College Road East, Princeton, NJ, United States, 08540 What is PDS Biotechnology's ISIN number?
PDS Biotechnology's international securities identification number is: US70465T1079 What is PDS Biotechnology's CUSIP number?
PDS Biotechnology's Committee on Uniform Securities Identification Procedures number is: 70465T107
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question